Physician
Abc Pediatrics & Medical PC
Abc Pediatrics & Medical PC was paid $5.90M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 55% of everything it billed.
33Billing provider infoABC PEDIATRICS & MEDICAL PC
BROOKLYN, NY 11230
BROOKLYN, NY 11230
33aNPI1609169812assigned 05/20/2011
33bProvider typePediatrics Physician
28Total paid$5.90M
24GClaims159,806
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#52 of 1,983
Median peer was paid$17K
This provider vs. median348×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,320 | $480K | |
| 2019 | 19,245 | $641K | |
| 2020 | 20,860 | $668K | |
| 2021 | 22,304 | $867K | |
| 2022 | 25,299 | $1.05M | |
| 2023 | 30,876 | $1.13M | |
| 2024incomplete | 27,902 | $1.06M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 55% | 49,459 | 41,621 | $3.22M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.2% | 5,721 | 5,696 | $484K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.5% | 5,601 | 5,335 | $442K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.5% | 23,138 | 22,297 | $326K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.1% | 7,411 | 7,175 | $302K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.9% | 3,474 | 3,471 | $291K |
| 99442 | 4.3% | 3,622 | 3,288 | $255K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.7% | 1,735 | 1,735 | $157K |
| 92587 | 1.9% | 4,104 | 4,100 | $114K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.3% | 719 | 709 | $75K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 550 | 550 | $50K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 9,110 | 8,706 | $39K |
55 more codes
| 90461 | <1% | 1,642 | $27K | |
| 99381 | <1% | 303 | $27K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,230 | $15K |
| 92567 | <1% | 1,327 | $13K | |
| 99383 | <1% | 107 | $11K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 838 | $8K |
| 69210 | <1% | 180 | $6K | |
| 94667 | <1% | 833 | $6K | |
| 99384 | <1% | 44 | $5K | |
| 94664 | <1% | 835 | $4K | |
| 99173 | <1% | 6,409 | $3K | |
| 81002 | <1% | 1,417 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 30 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 76 | $2K |
| 36400 | <1% | 97 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,401 | $1K |
| 99382 | <1% | 12 | $1K | |
| 90670 | <1% | 1,964 | $891.88 | |
| 90651 | <1% | 111 | $840.92 | |
| 99441 | <1% | 16 | $707.27 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 734 | $568.90 |
| 0071A | <1% | 14 | $490.28 | |
| 90716 | <1% | 898 | $472.27 | |
| 90686 | <1% | 3,162 | $452.44 | |
| 96127 | <1% | 80 | $353.11 | |
| 90710 | <1% | 398 | $333.19 | |
| 90677 | <1% | 452 | $288.91 | |
| 90655 | <1% | 56 | $265.44 | |
| 90744 | <1% | 1,574 | $244.67 | |
| 90707 | <1% | 376 | $221.09 | |
| 90633 | <1% | 1,713 | $182.26 | |
| 90656 | <1% | 335 | $180.34 | |
| 36416 | <1% | 3,862 | $157.88 | |
| 99072 | <1% | 1,542 | $154.80 | |
| 90734 | <1% | 137 | $146.62 | |
| 90713 | <1% | 992 | $100.00 | |
| 90700 | <1% | 1,517 | $50.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 204 | $30.66 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 14 | $30.18 |
| 90672 | <1% | 98 | $26.88 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 577 | $22.01 |
| 90698 | <1% | 829 | $17.85 | |
| 90619 | <1% | 472 | $0.16 | |
| 90671 | <1% | 31 | $0.02 | |
| 90715 | <1% | 378 | $0.02 | |
| 90685 | <1% | 120 | $0.01 | |
| 90681 | 0% | 76 | $0.00 | |
| 91300 | 0% | 12 | $0.00 | |
| 99000 | 0% | 686 | $0.00 | |
| 90647 | 0% | 1,306 | $0.00 | |
| 90696 | 0% | 323 | $0.00 | |
| 3008F | 0% | 912 | $0.00 | |
| 90680 | 0% | 285 | $0.00 | |
| 90660 | 0% | 32 | $0.00 | |
| 90657 | 0% | 93 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEVI, NATELA (PRESIDENT)